Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Bassetti

Showing results (21-30 of 740) with videos related to

Pageof 74
Sort By:
Expert Opinion on Investigational Drugs|September 25, 2014
Eravacycline for the treatment of intra-abdominal infectionsMatteo Bassetti, Elda Righi
Urologia|December 3, 2014
[Adequacy of antimicrobial therapy in urinary tract infections (UTI).]Matteo Bassetti, Alessia Carnelutti
Current Opinion in Critical Care|August 12, 2015
New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infectionsMatteo Bassetti, Elda Righi
Future Microbiology|February 18, 2015
Ceftolozane/tazobactam for the treatment of complicated urinary tract and intra-abdominal infectionsMatteo Bassetti, Elda Righi
Intensive Care Medicine|June 9, 2018
Antipathy against SDD is justified: YesJean-François Timsit, Matteo Bassetti
International Journal of Medical Informatics|November 20, 2025
Beyond explainability: Introducing shared reasoning fragilityDaniele Roberto Giacobbe, Matteo Bassetti
The Lancet. Infectious Diseases|January 30, 2023
Too many antibiotics for patients with COVID-19 despite low bacterial infectionsDaniele Roberto Giacobbe, Matteo Bassetti
Med (New York, N.Y.)|May 11, 2024
Cefepime-taniborbactam and CERTAIN-1: Can we treat carbapenem-resistant infections?Matteo Bassetti, Daniele Roberto Giacobbe
Expert Opinion on Pharmacotherapy|August 5, 2020
A look at the clinical, economic, and societal impact of antimicrobial resistance in 2020Matteo Bassetti, Daniele Roberto Giacobbe
Expert Opinion on Pharmacotherapy|December 3, 2019
Judging the appropriate therapy for carbapenem-resistant <i>Acinetobacter</i> infectionsMatteo Bassetti, Daniele Roberto Giacobbe
Pageof 74

Showing results (21-30 of 740) with videos related to

Sort By:
Pageof 74
Expert Opinion on Investigational Drugs|September 25, 2014
Eravacycline for the treatment of intra-abdominal infectionsMatteo Bassetti, Elda Righi
Urologia|December 3, 2014
[Adequacy of antimicrobial therapy in urinary tract infections (UTI).]Matteo Bassetti, Alessia Carnelutti
Current Opinion in Critical Care|August 12, 2015
New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infectionsMatteo Bassetti, Elda Righi
Future Microbiology|February 18, 2015
Ceftolozane/tazobactam for the treatment of complicated urinary tract and intra-abdominal infectionsMatteo Bassetti, Elda Righi
Intensive Care Medicine|June 9, 2018
Antipathy against SDD is justified: YesJean-François Timsit, Matteo Bassetti
International Journal of Medical Informatics|November 20, 2025
Beyond explainability: Introducing shared reasoning fragilityDaniele Roberto Giacobbe, Matteo Bassetti
The Lancet. Infectious Diseases|January 30, 2023
Too many antibiotics for patients with COVID-19 despite low bacterial infectionsDaniele Roberto Giacobbe, Matteo Bassetti
Med (New York, N.Y.)|May 11, 2024
Cefepime-taniborbactam and CERTAIN-1: Can we treat carbapenem-resistant infections?Matteo Bassetti, Daniele Roberto Giacobbe
Expert Opinion on Pharmacotherapy|August 5, 2020
A look at the clinical, economic, and societal impact of antimicrobial resistance in 2020Matteo Bassetti, Daniele Roberto Giacobbe
Expert Opinion on Pharmacotherapy|December 3, 2019
Judging the appropriate therapy for carbapenem-resistant <i>Acinetobacter</i> infectionsMatteo Bassetti, Daniele Roberto Giacobbe
Pageof 74